Skip to content

Application of shear wave dispersion imaging in diffuse abdominal lesions

Application of shear wave dispersion imaging in diffuse abdominal lesions

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900025445
Enrollment
Unknown
Registered
2019-08-26
Start date
2019-08-26
Completion date
Unknown
Last updated
2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver steatosis, chronic kidney disease

Interventions

Gold Standard:According to the steatosis test scoring model proposed by Thierry Poynard in 2005, patients with liver steatosis were divided into four groups: grade I, II, III and IV steatosis. Patien
data&#32
and&#32
diagnostic&#32
test&#32
results&#32
gender,&#32
GFR&#32
of&#32
patients&#32
with&#32
clinical&#32

Sponsors

Peking University People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Selection criteria for patients with hepatic steatosis: Liver steatosis was diagnosed according to clinical diagnostic criteria (diagnosis was completed by 1-2 clinically experienced attending physicians), with complete steatosis test results and liver function test results, aged 18-75 years; 2. Selection criteria for patients with chronic kidney disease (CKD): According to clinical diagnostic criteria, chronic kidney disease (diagnosed by 1-2 physicians with clinical experience), GFR (glomerular filtration rate) test results and complete renal function test results, age 18-75 years.

Exclusion criteria

Exclusion criteria: 1. The exclusion criteria for patients with hepatic steatosis were viral hepatitis, drug-induced liver disease, Wilson's disease, total parenteral nutrition and autoimmune liver disease. Severe underlying diseases (heart, kidney, brain, etc.); 2. Exclusion criteria for patients with chronic kidney disease (CKD): patients with various acute kidney diseases, including renal tuberculosis, renal mass, renal vascular disease, patients after kidney transplantation, patients with congenital solitary kidney, unilateral renal dysplasia or severe ascites, patients with hydronephrosis, multiple calculi in kidney or medullary sponge kidney, juvenile, non-adult Individuals with complete behavioral ability, no serious underlying diseases (heart, brain, etc.)

Design outcomes

Primary

MeasureTime frame
Shear wave dispersion;

Secondary

MeasureTime frame
Kidney size;

Countries

China

Contacts

Public ContactJiaan Zhu

Peking University People's Hospital

zhujiaan@pkuph.edu.cn+86 010-88325379

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026